694 related articles for article (PubMed ID: 34515981)
1. Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2.
Ebob OT; Babiaka SB; Ntie-Kang F
Nat Prod Bioprospect; 2021 Dec; 11(6):611-628. PubMed ID: 34515981
[TBL] [Abstract][Full Text] [Related]
2. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
[TBL] [Abstract][Full Text] [Related]
3. Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.
Omrani M; Keshavarz M; Nejad Ebrahimi S; Mehrabi M; McGaw LJ; Ali Abdalla M; Mehrbod P
Front Pharmacol; 2020; 11():586993. PubMed ID: 33679384
[TBL] [Abstract][Full Text] [Related]
4. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
5. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
[TBL] [Abstract][Full Text] [Related]
6. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19.
Saied EM; El-Maradny YA; Osman AA; Darwish AMG; Abo Nahas HH; Niedbała G; Piekutowska M; Abdel-Rahman MA; Balbool BA; Abdel-Azeem AM
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834174
[TBL] [Abstract][Full Text] [Related]
8. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
9. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
10. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
[TBL] [Abstract][Full Text] [Related]
11. The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2.
Chen HF; Wang WJ; Chen CY; Chang WC; Hsueh PR; Peng SL; Wu CS; Chen Y; Huang HY; Shen WJ; Wang SC; Hung MC
Elife; 2023 Aug; 12():. PubMed ID: 37642993
[TBL] [Abstract][Full Text] [Related]
12. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro.
Ngwe Tun MM; Toume K; Luvai E; Nwe KM; Mizukami S; Hirayama K; Komatsu K; Morita K
J Nat Med; 2022 Mar; 76(2):402-409. PubMed ID: 35006524
[TBL] [Abstract][Full Text] [Related]
13. Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.
Ayatollahi SA; Sharifi-Rad J; Tsouh Fokou PV; Mahady GB; Ansar Rasul Suleria H; Krishna Kapuganti S; Gadhave K; Giri R; Garg N; Sharma R; Ribeiro D; Rodrigues CF; Reiner Ž; Taheri Y; Cruz-Martins N
Front Pharmacol; 2021; 12():575877. PubMed ID: 34267652
[TBL] [Abstract][Full Text] [Related]
14. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.
Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299
[TBL] [Abstract][Full Text] [Related]
15. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
Krishna G; Pillai VS; Veettil MV
Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
17. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options.
Sohrab SS; Suhail M; Kamal MA; Azhar EI
Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Polyphenolic Natural Products as SARS-CoV-2 M
Krüger N; Kronenberger T; Xie H; Rocha C; Pöhlmann S; Su H; Xu Y; Laufer SA; Pillaiyar T
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259339
[TBL] [Abstract][Full Text] [Related]
19. An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity.
Shagufta ; Ahmad I
ChemistrySelect; 2021 Nov; 6(42):11502-11527. PubMed ID: 34909460
[TBL] [Abstract][Full Text] [Related]
20. Structure of M
Jin Z; Du X; Xu Y; Deng Y; Liu M; Zhao Y; Zhang B; Li X; Zhang L; Peng C; Duan Y; Yu J; Wang L; Yang K; Liu F; Jiang R; Yang X; You T; Liu X; Yang X; Bai F; Liu H; Liu X; Guddat LW; Xu W; Xiao G; Qin C; Shi Z; Jiang H; Rao Z; Yang H
Nature; 2020 Jun; 582(7811):289-293. PubMed ID: 32272481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
